GlassScriptPhysician profile
Rajiv Nair
NPI 1780609776
$28,116.54
in general payments reported to CMS, 2019-2025
26 companies · $9,963 in 2025
The $9,963 reported for 2025 was more than what 94% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,125 · 2020: $617 · 2021: $504 · 2022: $3,292 · 2023: $2,070 · 2024: $11K · 2025: $9,963.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $16K · Food and Beverage: $6,757.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $15,820.92 |
| Food and Beverage | $6,756.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $8,641.10 | 2019-2025 | Selectra, Acticor 7 Vr-T Dx, Amvia Edge |
| Medtronic, INC. | $5,756.81 | 2021-2025 | Micra, Azure Xt Dr Mri Surescan, Pulseselect |
| Medical Device Business Services, INC. | $4,513.12 | 2019-2024 | Carto 3 |
| Boston Scientific Corporation | $3,949.75 | 2022-2025 | Farapulse |
| Abbott Laboratories | $2,105.08 | 2019-2025 | Aveir, Accent, Cardiomems |
| Endologix LLC | $973.49 | 2019-2024 | Alto Abdominal Stent Graft System |
| Medtronic Vascular, INC. | $708.38 | 2019-2020 | |
| Biosense Webster, INC. | $664.11 | 2019-2025 | Carto 3, Qdot Micro |
| Cordis US Corp. | $249.35 | 2025 | |
| Baxter Healthcare | $104.52 | 2022-2025 | Hillrom - Carnation Ambulatory Monitor |
| Janssen Pharmaceuticals, INC | $80.56 | 2021-2022 | |
| Ancora Heart, INC. | $57.91 | 2022 | |
| Sanofi-Aventis U.S. LLC | $34.93 | 2021-2022 | |
| Abiomed | $33.07 | 2025 | |
| Cleerly, INC. | $29.81 | 2025 | Cleerly Ischemia, Cleerly Labs |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $28.09 | 2024 | Assure Wcd |
| Pfizer INC. | $24.66 | 2024 | |
| Cardiva Medical, INC. | $24.49 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Terumo Medical Corporation | $24.02 | 2024 | Tr Band, Angio-Seal |
| Elutia, INC. | $21.40 | 2019 | |
| Cvrx, INC. | $20.03 | 2024 | Barostim Neo System |
| E.R. Squibb & Sons, L.L.C. | $19.36 | 2024 | Camzyos |
| Davol INC. | $18.27 | 2024 | Arista Ah Flexitip |
| Atricure, INC. | $18.08 | 2022 | |
| Daiichi Sankyo INC. | $16.15 | 2024 | Injectafer |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajiv Nair listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.